The anti-inflammatory effect of GRs is promoted by HDAC2, and studies have revealed that HDAC2 expression is decreased in patients with severe asthma and may be involved in the development of glucocorticoid resistance (Irvin et al., 2014). The gene discussed is BCL2A1; the disease is asthma.